Shareholder structure
QIAGEN has a truly global investor base comprised of more than 335 identified institutional investors distributed around the world, including more than a half in North America, about one-third in Europe and the remaining shares in the Asia-Pacific/Japan region. Members of the Managing Board and the supervisory Board in total held approximately 2.5 % of QIAGEN's outstanding common shares at the end of 2016.
| Name | Holdings | % Stake |
| BlackRock, Inc., United States | 21,500 | 9.31 |
| Franklin Resources, Inc., United States | 18,500 | 8.01 |
| PRIMECAP Management Company, United States | 16,179 | 7.01 |
Status: August 2018
Related pages
